Recombinant IGF-1 therapy has been approved to increase linear growth, and therefore height, in humans, spurring an increasing interest in the potential use of IGF-1 for the treatment of hearing loss (Yamahara et al., 2015). This evidence concerns the gene IGF1 and hearing loss disorder.